The ROSE Registry will determine the long-term safety and effectiveness of Macroplastique in the treatment of female stress urinary incontinence (SUI) due to intrinsic sphincter deficiency (ISD).
The Rose Registry is a five-year post-market study of the safety and effectiveness of Macroplastique in the treatment of female stress urinary incontinence due to intrinsic sphincter deficiency.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
276
Macroplastique is an injectable soft-tissue bulking agent used to treat stress urinary incontinence (SUI) primarily due to intrinsic sphincter deficiency (ISD).
Urological Associates of Southern Arizona
Tucson, Arizona, United States
Kaiser Permanente Southern California-Irvine Medical Center
To describe the incidence of additional or alternative treatment for stress urinary incontinence due to ISD following up to two Macroplastique treatments over a 5 year period.
To describe the incidence of additional or alternative treatments
Time frame: 5-years
To describe the incidence of genitourinary and treatment related adverse events, including transient symptoms associated with the injection procedure.
To describe the incidence of genitourinary and treatment related adverse events
Time frame: 5-years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Irvine, California, United States
Univeristy of California- Irvine
Orange, California, United States
The University of California- of San Diego
San Diego, California, United States
Urology Associates, PC
Englewood, Colorado, United States
Specialists in Urology
Naples, Florida, United States
The Florida Bladder Institute
Naples, Florida, United States
Northwestern University Prentice Women's Hospital
Chicago, Illinois, United States
Deaconess Clinic
Newburgh, Indiana, United States
The University of Michigan Health Center
Ann Arbor, Michigan, United States
...and 9 more locations